Low-grade Myofibroblastic Sarcoma at the Base of the Tongue by MORI Tomoaki et al.
Introduction
　Low-grade myobroblastic sarcoma（LGMS）represents a distinct atypical myobroblastic 
tumor with bromatosis-like features and a predilection for the head and neck1）.  LGMS 
occurs primarily in adult patients with a slight male predominance ; children are rarely 
affected1）.  Although LGMS shows a wide anatomical distribution, it is most common in the 
head and neck regions, especially in the tongue and oral cavity2, 3）.  Rare cases involving the 
salivary gland and the nasal cavity / paranasal sinus have been reported.  Here we report a 
case of LGMS at the base of the tongue.  The clinical, histological, and immunohistochemi-
cal features are described.
Case Report
　A 56-year-old man presented at our hospital with a painless mass in the base of the 
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Abstract : Low-grade myofibroblastic sarcoma（LGMS）represents a distinct 
atypical myofibroblastic tumor that occurs at several sites, primarily within 
the head and neck regions.  A painless, enlarged mass is the most common 
clinical presentation, but a denitive diagnosis requires both histopathological 
and immunohistochemical analyses.  Histologically, LGMS commonly presents 
as a cellular lesion composed of spindle-shaped tumor cells arranged primarily 
in fascicles with a diffusely inltrative pattern.  Immunohistochemically, LGMS 
shows positive staining for at least one myogenic marker, such as desmin or 
muscle actin.  Here we report a case of LGMS in the base of the tongue. 
Our case showed positive immunostaining for desmin and vimentin, and was 
thus diagnosed as LGMS.  The patient received surgery, but no chemotherapy 
or radiotherapy, and was completely without evidence of the disease 38 
months after the surgery.
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tongue and difculty in swallowing.  Laryngeal beroscopy revealed a tumor at the base of 
the tongue（Fig. 1）.
　Magnetic resonance imaging（MRI）revealed a tumor mass that was well-demarcated and 
myxomatous without calcication.  The airway space was stenosed by the tumor.  Other 
analyses were negative for malignancies or tumor metastasis（Fig. 2）.
　Exfoliative cytology as well as forceps and ne needle aspiration cytology revealed no 
malignant cells.  We therefore diagnosed a benign tumor of the base of the tongue, and sur-
gery was performed accordingly.  The tumor was covered by a capsule and was not adhered 
to the surrounding muscles and pharyngeal mucus, allowing resection with the capsule intact.
　The patient received no chemotherapy or radiotherapy and was completely without evi-
dence of disease 38 months after the surgery（Fig. 3）.
Fig. 3.　Postoperative MRI revealed no residual 
tumor, recurrence, or metastasis.
Fig. 2.　Preoperative MRI revealed a tumor at the 
base of the tongue. The mass was well-
demarcated and myxomatous without calci-
cation. MRI conrmed stenosis of the airway 
due to the tumor.
Fig. 1.　Tumor at the base of the tongue. The 
airway space was stenosed by the tumor.
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Histopathological ndings（Fig. 4）
　The resected tissue mass was 51×49×44 mm3.  Sectioning revealed a well-demarcated 
nodular tumor measuring 42 mm.  The tumor was solid, myxomatous, and appeared xant-
hous without necrotic foci or hemorrhage.
　Microscopic examination of the resected specimen showed spindle-shaped, elongated and 
stellate tumor cells embedded in a myxoid matrix.
　Immunohistochemical examination of the tumor sections showed positive staining for 
desmin and vimentin.  Immunostaining was negative for smooth muscle actin（SMA）, 
muscle-specific actin（MSA）, epithelial membrane antigen（EMA）, S-100 protein, AE1 /
AE3, CD34, and anaplastic lymphoma kinase（ALK）.  The patient was diagnosed as having 
LGMS.
Discussion
　LGMS represents a distinct atypical myobroblastic tumor with bromatosis-like features 
and a predilection for the head and neck 1）.  In most cases, patients present with a painless 
swelling or an enlarged mass, and pain or related symptoms are rarely reported.  In general, 
the mass involved is rm with pale and brous cut surfaces and primarily indistinct margins, 
although the minority of these neoplasms is well circumscribed with well-dened margins. 
Fig. 4.　On sectioning, a well-demarcated nodular tumor, measuring 42 mm 
was observed. The tumor was solid, myxomatous, and appeared 
xanthous without necrotic foci or hemorrhage. The tumor was 
immunopositive for desmin and vimentin, but negative for SMA, 
MSA, EMA S-100 protein, AE1 / AE3, CD34, and ALK.
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Radiologically, these lesions have a destructive growth pattern2）.
　Histologically, most cases of LGMS are characterized by a diffusely infiltrative growth 
pattern, and by deeply located neoplasms ; tumor cells may grow between individual skeletal 
muscle bers.  Most cases are composed of cellular fascicles or show a storiform growth 
pattern of spindle-shaped tumor cells.  Importantly, neoplastic cells show at least focally 
moderate nuclear atypia with enlarged, hyperchromatic, and irregular nuclei and they show 
slightly increased proliferative activity.
　The reported immunohistochemical ndings vary for myobroblast sarcoma（MS）.  Ment-
zel et al 2） reported that MS was positive for vimentin, SMA, calponin, and fibronectin, 
rarely positive for desmin, and negative for laminin and type IV collagen, while Montgom-
ery et al 4）, Eyden et al 5, 6）and Coffin et al 7）reported SMA immunopositivity in 13 of 15 
tumors, MSA staining in 7 of 9, and desmin in 6 of 14, with all of these cases negative for 
all cytokeratins, S-100 protein, and CD34.  In a recent study, Meng et al 8） reported that 
MS tumor cells strongly and extensively expressed vimentin（20 / 20）, SMA（18 / 20）, MSA
（16 / 20）, and bronectin（20 / 20）, while only 2 cases（2 / 20）focally expressed desmin and 
type IV collagen, h-caldesmon, laminin, ALK1, and CD68 showed uniformly immunonegative 
staining.  Based on these and our results, we conclude that myogenic markers are useful for 
the diagnosis of LGMS.
　Clinically, local MS recurrences are common, whereas metastasis occurs only rarely and 
then only after a prolonged period.  Although LGMSs are low-grade tumors, they exhibit a 
pattern of aggressive local spread with eventual metastatic dissemination1）.  The treatment 
for MS, as for other types of sarcomas, is surgical excision with wide margins.  Adjuvant 
therapies such as chemotherapy and radiotherapy have also been used in some cases 8-10）, 
although the optimal treatment of LGMS remains ill-dened.
　In our case, surgery alone was considered to be adequate and the patient was disease-free 
at the most recent oral examination, 38 months postoperatively.  Such patients should be 
carefully observed at follow-ups.
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